Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity (2020)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1038/s41574-019-0310-7
- Subjects: CIRCUNFERÊNCIA ABDOMINAL; SINAIS VITAIS; PRÁTICA CLÍNICA; CONSENSO; ÍNDICE DE MASSA CORPORAL; MORBIDADE; SOBREPESO; OBESIDADE; FATORES DE RISCO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Nature reviews endocrinology
- ISSN: 1759-5029
- Volume/Número/Paginação/Ano: v. 16, n. 3, p. 177-189, 2020
- Status:
- Artigo aberto em periódico híbrido (Hybrid Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
ROSS, Robert et al. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nature reviews endocrinology, v. 16, n. 3, p. 177-189, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41574-019-0310-7. Acesso em: 10 maio 2026. -
APA
Ross, R., Neeland, I. J., Yamashita, S., Shai, I., Seidell, J., Magni, P., et al. (2020). Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nature reviews endocrinology, 16( 3), 177-189. doi:10.1038/s41574-019-0310-7 -
NLM
Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, Santos Filho RD dos, Arsenault B, Cuevas A, Hu FB. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity [Internet]. Nature reviews endocrinology. 2020 ; 16( 3): 177-189.[citado 2026 maio 10 ] Available from: https://doi.org/10.1038/s41574-019-0310-7 -
Vancouver
Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, Santos Filho RD dos, Arsenault B, Cuevas A, Hu FB. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity [Internet]. Nature reviews endocrinology. 2020 ; 16( 3): 177-189.[citado 2026 maio 10 ] Available from: https://doi.org/10.1038/s41574-019-0310-7 - Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
- Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário]
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
- Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
- USPSTF recommendation on screening for lipid disorders in children and adolescents. [Carta]
- Down the rabbit hole: reviewing the evidence for primary prevention of cardiovascular disease in people with obesity
- Relation Between Self-Reported Physical Activity Level, Fitness, and Cardiometabolic Risk
- Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know
- The Role of Statins in Current Guidelines
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
